Back to search
Radio Dermatitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Radio Dermatitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Radio Dermatitis trials you may qualify forThe goal of this interventional study is to see if the daily use of red light therapy called photobiomodulation can help sore skin and sore mouths in children h…
Most patients with cancer or haematological malignancies who receive chemotherapy - broadly defined to include targeted therapies and immunotherapy - and/or ext…
The primary objective consisted of avoiding deterioration and/or restoring the integrity of the skin of patients treated by radiotherapy, right from the first s…
Radiodermatitis is a major problem in oncologic patients, fat grafts previously used for cosmetic procedures have been shown to have regenerative power due to t…
Most breast cancer patients undergoing radiotherapy develop radiodermatitis, making it one of the most prevalent adverse events during cancer treatment. The sev…
The purpose of this study is to characterize the skin microbiome profile of breast cancer patients before and after receiving Radio Therapy treatments, and eval…
Radiodermatitis and radiation mucositis were the most frequent side-effect during the course of radiotherapy, especially when concurrent chemoradiotherapy appli…
The aim of this randomized trial is to compare the rate of radio-dermatitis grade 2+ (NCI-CTC V3.0) in patients receiving radiotherapy+Erbitux+placebo versus in…